An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
NCT05669794
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Sponsor
AbbVie